Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Check which altcoins have active Github in 2024 to gauge real development engagement. Compare commit activity and contributor counts to identify strong projects.
26,463 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Three top clean energy ETFs have surged more than 50% over the past year, offering divergent paths to the green trans...
A mid-week move in Constellation Energy shares sparked questions about momentum and fundamentals. This piece breaks d...
As gas prices trend higher, Costco’s fuel discounts and bulk-buying model could attract more shoppers. This practical...
Lawmakers delay a major stablecoin bill, triggering renewed frustration across crypto traders as markets react to pol...
Want to furnish on a budget without sacrificing style? This guide shares 10 practical tips to find tips best deals us...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
Buffett’s moves often spark debates about dividend stocks. This article digs into the idea behind 'warren buffett own...
Bitcoin slid to about $79,679 as geopolitical tensions flare, but the week remains on track for a sixth straight week...
A viral moment where a famous author linked MAGA to an addictive pattern reveals powerful lessons for personal financ...
A prominent real estate fund made a bold $5 million move on InvenTrust Properties as the stock trailed the S&P 500. T...
A personal-finance reporter runs a controlled test with ChatGPT to draft a market update, revealing both efficiency g...